CA - Knight Therapeutics Inc. (KHTRF) Q4 2023 Earnings Call Transcript
2024-03-21 12:15:22 ET
Knight Therapeutics Inc. (KHTRF)
Q4 2023 Earnings Conference Call
March 21, 2024 8:30 AM ET
Company Participants
Samira Sakhia - President and Chief Executive Officer and Director
Arvind Utchanah - Chief Financial Officer
Amal Khouri - Chief Business Officer
Conference Call Participants
Douglas Miehm - RBC Capital Markets
Rahul Sarugaser - Raymond James Ltd
Presentation
Operator
Good morning, ladies and gentlemen. My name is Sylvie, and I will be your operator today. Welcome to the Knight Therapeutics’ Fourth Quarter and Yearend 2023 Results Conference Call.
Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today’s discussion may by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements.
The company considers these assumptions on which the forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries, may ultimately prove to be incorrect. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as results of new information or future events, except as required by law....
Knight Therapeutics Inc. (KHTRF) Q4 2023 Earnings Call Transcript